Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 21.3% in First Three Quarters of 2023

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 463.5 million yuan in the first three quarters of 2023, down 21.3% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, down 1.9% year-on-year.

At the end of the reporting period, it had 10.2 billion yuan in total assets and 485.2 million yuan in total liabilities, with a liability-to-asset ratio of 4.8%.